PE20140888A1 - FAMILY OF POLYAMINATED ARYLETHYLAMIDES COMPOUNDS, AND THEIR COSMETIC OR DERMOCOSMETIC APPLICATIONS - Google Patents
FAMILY OF POLYAMINATED ARYLETHYLAMIDES COMPOUNDS, AND THEIR COSMETIC OR DERMOCOSMETIC APPLICATIONSInfo
- Publication number
- PE20140888A1 PE20140888A1 PE2013001491A PE2013001491A PE20140888A1 PE 20140888 A1 PE20140888 A1 PE 20140888A1 PE 2013001491 A PE2013001491 A PE 2013001491A PE 2013001491 A PE2013001491 A PE 2013001491A PE 20140888 A1 PE20140888 A1 PE 20140888A1
- Authority
- PE
- Peru
- Prior art keywords
- compounds
- polyaminated
- cosmetic
- agents
- arylethylamides
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 239000002537 cosmetic Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 102000016942 Elastin Human genes 0.000 abstract 1
- 108010014258 Elastin Proteins 0.000 abstract 1
- -1 N - ((4-IMIDAZOLYL) ETHYL) -ALPHA, GAMMA-DIAMINOBUTANAMIDE Chemical compound 0.000 abstract 1
- DPUYCSDGMSDKKV-MKBYFEBXSA-N N-Acetyl-L-leucyl-L-isoleucylglycyl-L-valyl-N-methyl-L-prolinamide Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC DPUYCSDGMSDKKV-MKBYFEBXSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 239000003212 astringent agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000006227 byproduct Substances 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 229920002549 elastin Polymers 0.000 abstract 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000013595 glycosylation Effects 0.000 abstract 1
- 238000006206 glycosylation reaction Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A COMPUESTOS DE ARILETILAMIDA POLIAMINADO DE FORMULA (II) DONDE: R ES a) b), c) O d); n ES DE 1 A 2. SON COMPUESTOS PREFERIDOS: N-((4-IMIDAZOLIL)ETIL)-ALFA, GAMMA-DIAMINOBUTANAMIDA; N-((4-IMIDAZOLIL)ETIL)-ALFA,BETA-DIAMINOPROPANAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION COSMETICA O DERMOCOSMETICA QUE COMPRENDE AL COMPUESTO DE FORMULA (II), Y A UN ADYUVANTE FISIOLOGICAMENTE COMPATIBLE CON LA PIEL, LA CANTIDAD DEL COMPUESTO ES DE 0,01 % Y 1% EN PESO DEL TOTAL DE LA COMPOSICION. ADEMAS LA COMPOSICION COMPRENDE AGENTES QUE ESTIMULAN LA SINTESIS DE COLAGENO O DE ELASTINA, AGENTES QUE AUMENTAN LA PROLIFERACION CELULAR, ANTIOXIDANTES, ASTRINGENTES, ENTRE OTROS. DICHOS COMPUESTOS SON AGENTES INHIBIDORES DE LOS DANOS DEL ADN INDUCIDO POR LOS SUBPRODUCTOS DE LA GLICOSILACION NO ENZIMATICA DE LOS TEJIDOS CUTANEOSREFERS TO POLYAMINATED ARYLETHYLAMIDE COMPOUNDS OF FORMULA (II) WHERE: R IS a) b), c) OR d); n IS 1 TO 2. PREFERRED COMPOUNDS ARE: N - ((4-IMIDAZOLYL) ETHYL) -ALPHA, GAMMA-DIAMINOBUTANAMIDE; N - ((4-IMIDAZOLIL) ETHYL) -ALPHA, BETA-DIAMINOPROPANAMIDE, AMONG OTHERS. IT ALSO REFERS TO A COSMETIC OR DERMOCOSMETIC COMPOSITION THAT INCLUDES THE COMPOUND OF FORMULA (II), AND TO A PHYSIOLOGICALLY COMPATIBLE ADJUVANT WITH THE SKIN, THE AMOUNT OF THE COMPOUND IS 0.01% AND 1% BY WEIGHT OF THE TOTAL COMPOSITION. IN ADDITION THE COMPOSITION INCLUDES AGENTS THAT STIMULATE THE SYNTHESIS OF COLLAGEN OR ELASTIN, AGENTS THAT INCREASE CELLULAR PROLIFERATION, ANTIOXIDANTS, ASTRINGENTS, AMONG OTHERS. SUCH COMPOUNDS ARE INHIBITING AGENTS OF DNA DAMAGE INDUCED BY THE BY-PRODUCTS OF NON-ENZYMATIC GLYCOSYLATION OF SKIN TISSUES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MC2588A MC200154A1 (en) | 2012-07-02 | 2012-07-02 | Family of arylethylamides polyamino compounds, and their cosmetic or dermocosmetic applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20140888A1 true PE20140888A1 (en) | 2014-08-08 |
Family
ID=47624478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013001491A PE20140888A1 (en) | 2012-07-02 | 2013-07-01 | FAMILY OF POLYAMINATED ARYLETHYLAMIDES COMPOUNDS, AND THEIR COSMETIC OR DERMOCOSMETIC APPLICATIONS |
Country Status (7)
| Country | Link |
|---|---|
| CN (1) | CN103524373B (en) |
| AR (1) | AR091640A1 (en) |
| BR (1) | BR102013017027B1 (en) |
| CO (1) | CO7160009A1 (en) |
| MC (1) | MC200154A1 (en) |
| MX (1) | MX2013007630A (en) |
| PE (1) | PE20140888A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2711990B1 (en) * | 1993-11-05 | 1995-12-08 | Exsymol Sa | Pseudodipeptide product having an imidazole group, and therapeutic, cosmetological and agrifood applications. |
| FR2833165B1 (en) * | 2001-12-10 | 2004-07-30 | Oreal | USE OF HYDROXYLATED BENZOFURANE DERIVATIVES FOR INHIBITING GLYCATION, COMPOSITION COMPRISING THE SAME AND METHOD OF TREATMENT. |
-
2012
- 2012-07-02 MC MC2588A patent/MC200154A1/en unknown
-
2013
- 2013-06-28 MX MX2013007630A patent/MX2013007630A/en unknown
- 2013-07-01 BR BR102013017027-5A patent/BR102013017027B1/en not_active IP Right Cessation
- 2013-07-01 PE PE2013001491A patent/PE20140888A1/en active IP Right Grant
- 2013-07-01 AR ARP130102343 patent/AR091640A1/en not_active Application Discontinuation
- 2013-07-01 CN CN201310271964.5A patent/CN103524373B/en not_active Expired - Fee Related
- 2013-07-03 CO CO13156117A patent/CO7160009A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR102013017027B1 (en) | 2021-01-05 |
| CN103524373A (en) | 2014-01-22 |
| CO7160009A1 (en) | 2015-01-15 |
| MX2013007630A (en) | 2014-01-21 |
| HK1193105A1 (en) | 2014-09-12 |
| MC200154A1 (en) | 2013-01-23 |
| CN103524373B (en) | 2016-12-28 |
| BR102013017027A2 (en) | 2015-06-23 |
| AR091640A1 (en) | 2015-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX384521B (en) | ARYL OR HETEROARYL SUBSTITUTED BENZENE COMPOUNDS. | |
| MX2015004771A (en) | Methods of treating cancer. | |
| ECSP109987A (en) | METHODS AND USEFUL COMPOUNDS TO PREPARE INHIBITORS OF THE 2-GLUCOSE CO-TRANSPORTER SODIUM | |
| UY33238A (en) | "Compounds as bradykinin-b1 antagonists" | |
| CU24269B1 (en) | 3- PIRIMIDIN- 4-IL- OXAZOLIDIN- 2- INHIBITING WAVES OF THE MUTANT HDI | |
| UY31072A1 (en) | IMIDAZOPIRIDAZINAS REPLACED AS INHIBITORS OF CINASA DE LIPIDO | |
| EA200701799A1 (en) | TRANS-CAROTINOIDS, SYNTHESIS OF SPECIFIED CAROTINOIDS, OBTAINING COMPOSITIONS AND THEIR APPLICATION | |
| UY33541A (en) | N - ((6-AMINO-PIRIDIN-3-IL) -METIL) -HETEROARIL-CARBOXAMIDAS | |
| CU20110204A7 (en) | SUBSTITUTED 1-CYANOETHYLETHYCLIC CARBOXAMIDE 750 COMPOUNDS | |
| BRPI0721905B8 (en) | Proteasome inhibitor compound, its pharmaceutical composition and its use | |
| MX2021015761A (en) | POLYPEPTIDES. | |
| UY31219A1 (en) | N- [3- (2,6-DICLOROPHENIL) -5-ALQUILO-1,2-OXAZOL-4-IL SUBSTITUTED CARBAMATES AND 1- [3- (2,6-DICLOROPHENYL) -5-METHYL-1,2- OXAZOL-4-IL] SUBSTITUTED UREAS AS WELL AS ISOMEROS, PHARMACEUTICAL SALTS AND USES OF SUCH COMPOUNDS | |
| PA8848201A1 (en) | AMINOTETRAHYDROPIRANS AS INHIBITORS OF DIPEPTIDIL PEPTIDASA-IV FOR THE TREATMENT OR PREVENTION OF DIABETES | |
| SV2011003802A (en) | USEFUL TRIAZOL DERIVATIVES FOR THE TREATMENT OF DISEASES | |
| UA108219C2 (en) | ANTI-PARASITER DIGIDROAZOLE COMPOUNDS AND COMPOSITION CONTAINING THEM (OPTIONS) | |
| PE20091101A1 (en) | 3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO [5,1-d] [1,2,3,5-TETRACINE-8-CARBOXYL ACID AMIDES AND ITS USE | |
| UY32918A (en) | NEW COMPOUNDS OF 2-PIRIDONA | |
| CR20140071A (en) | NEW 4-PIPERIDINYL COMPOUNDS FOR USE AS TANKIRASA INHIBITORS | |
| CL2011000544A1 (en) | Compounds derived from benzamide n substituted by heterocycle, cannabinoid receptor ligands; pharmaceutical composition; and its use to treat pain, among other diseases. | |
| EA201390010A1 (en) | SUBSTITUTED TRIAZOLOPIRIDINES | |
| IN2012DN01345A (en) | ||
| EA201291446A1 (en) | COMPOSITIONS FOR SKIN CARE, CONTAINING SUBSTITUTED MONOAMINES | |
| ECSP067120A (en) | 3-AMINOCICLOPENTANOCARBOXAMIDS AS CHEMIOKIN RECEPTORS MODULATORS | |
| CR20120502A (en) | USE OF NEW PAN-CDK INHIBITORS TO TREAT TUMORS | |
| MX2011013130A (en) | Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |